Karen Grepin
Karen Grepin
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Maternal education and child mortality in Zimbabwe
KA Grépin, P Bharadwaj
Journal of health economics 44, 97-117, 2015
Women are most affected by pandemics—lessons from past outbreaks
C Wenham, J Smith, SE Davies, H Feng, KA Grépin, S Harman, ...
Nature 583 (7815), 194-198, 2020
Approaches and Alternatives to the Wealth Index to Measure Socioeconomic Status Using Survey Data: A Critical Interpretive Synthesis
MG Mathieu J. P. Poirier, Karen A. Grépin
Social Indicators Research, 2019
Evidence of the effectiveness of travel-related measures during the early phase of the COVID-19 pandemic: a rapid systematic review
KA Grépin, TL Ho, Z Liu, S Marion, J Piper, CZ Worsnop, K Lee
BMJ global health 6 (3), e004537, 2021
Disruptions in maternal health service use during the COVID-19 pandemic in 2020: experiences from 37 health facilities in low-income and middle-income countries
Z Aranda, T Binde, K Tashman, A Tadikonda, B Mawindo, D Maweu, ...
BMJ global health 7 (1), e007247, 2022
HIV donor funding has both boosted and curbed the delivery of different non-HIV health services in sub-Saharan Africa
KA Grépin
Health affairs 31 (7), 1406-1414, 2012
Global coordination on cross-border travel and trade measures crucial to COVID-19 response
K Lee, CZ Worsnop, KA Grépin, A Kamradt-Scott
The Lancet 395 (10237), 1593-1595, 2020
China’s role as a global health donor in Africa: what can we learn from studying under reported resource flows?
KA Grépin, VY Fan, GC Shen, L Chen
Globalization and health 10, 1-11, 2014
Patterns of demand for non-Ebola health services during and after the Ebola outbreak: panel survey evidence from Monrovia, Liberia
B Morse, KA Grépin, RA Blair, L Tsai
BMJ Global Health 1, e000007, 2016
More than a public health crisis: A feminist political economic analysis of COVID-19
J Smith, SE Davies, H Feng, CCR Gan, KA Grépin, S Harman, ...
Global public health 16 (8-9), 1364-1380, 2021
Private sector an important but not dominant provider of key health services in low-and middle-income countries
KA Grépin
Health Affairs 35 (7), 1214-1221, 2016
Impact of the COVID-19 pandemic and response on the utilisation of health services in public facilities during the first wave in Kinshasa, the Democratic Republic of the Congo
C Hategeka, SE Carter, FM Chenge, EN Katanga, G Lurton, SMN Mayaka, ...
BMJ global health 6 (7), e005955, 2021
Conceptualizing integration: a framework for analysis applied to neglected tropical disease control partnerships
KA Grepin, MR Reich
PLoS Neglected Tropical Diseases 2 (4), e174, 2008
The failure of private health services: COVID-19 induced crises in low-and middle-income country (LMIC) health systems
O David Williams, KC Yung, KA Grépin
Global Public Health 16 (8-9), 1320-1333, 2021
Understanding the challenges associated with the use of data from routine health information systems in low-and middle-income countries: a systematic review
K Hoxha, YW Hung, BR Irwin, KA Grepin
Health Information Management Journal 51 (3), 135-148, 2022
The impact of an mHealth monitoring system on health care utilization by mothers and children: an evaluation using routine health information in Rwanda
H Ruton, A Musabyimana, E Gaju, A Berhe, KA Grépin, J Ngenzi, ...
Health policy and planning 33 (8), 920-927, 2018
Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection
G Alter, G Hatzakis, CM Tsoukas, K Pelley, D Rouleau, R LeBlanc, ...
The Journal of Immunology 171 (1), 477-488, 2003
Using routine health information data for research in low-and middle-income countries: a systematic review
YW Hung, K Hoxha, BR Irwin, MR Law, KA Grépin
BMC Health Services Research 20, 1-15, 2020
Association between the quality of contraceptive counseling and method continuation: findings from a prospective cohort study in social franchise clinics in Pakistan and Uganda
NM Chakraborty, K Chang, B Bellows, KA Grépin, W Hameed, A Kalamar, ...
Global Health: Science and Practice 7 (1), 87-102, 2019
The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indications
ER Berndt, IM Cockburn, KA Grepin
Pharmacoeconomics 24, 69-86, 2006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20